Pharmacological and/or surgical closure of a hemodynamically significant patent ductus arteriosus (PDA) in the very preterm infant has been the standard of care over the past few decades. However, the ...

Credit: Getty Images. Evidence suggests that patent ductus arteriosus comprises anywhere from 5% to 10% of all congenital heart disease. Although the majority of congenital heart diseases (CHD) are ...

Medical and surgical interventions are widely used to close a persistently patent ductus arteriosus in preterm infants. Objective evidence to support these practices is lacking, causing some to ...

The cyclooxygenase inhibitor ibuprofen may be used to treat patent ductus arteriosus (PDA) in preterm infants. Whether selective early treatment of large PDAs with ibuprofen would improve short-term ...

Patent ductus arteriosus (PDA) is a common condition in preterm infants in which the fetal blood vessel connection between the aorta and the pulmonary artery does not close normally after birth. The ...

Patent Ductus Arteriosus is a congenital defect of the heart where the fetal passage between pulmonary artery and aorta remains open and causes excess pulmonary blood flow. The causes of Mitral valve ...

In a clinical report published in the May issue of Pediatrics, the American Academy of Pediatrics presents updated guidance on the evaluation and treatment of patent ductus arteriosus (PDA) in preterm ...

Patent ductus arteriosus (PDA), one of the more common cardiac defects present at birth, is the persistence of an opening between the pulmonary artery and aorta. This opening is as a result of failure ...

According to doctors, the infant, weighing 4.5 kg, was experiencing poor weight gain, recurrent respiratory infections, breathing difficulties and weakness due to Patent Ductus Arteriosus ...

Patent Ductus arteriosus is the second commonest congenital birth defect of the heart and can cause heart failure; however majority of these defect close spontaneously after birth. Patent Ductus ...